Should You Buy Quotient Ltd (QTNT) Stock After it Has Fallen 2.82% in a Week?

Tuesday, September 29, 2020 3:20 PM | InvestorsObserver Analysts

The market has been high on Quotient Ltd (QTNT) stock recently. QTNT gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Quotient Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on QTNT!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With QTNT Stock Today?

Quotient Ltd (QTNT) stock has fallen -2.82% while the S&P 500 has risen 1.61% as of 3:18 PM on Tuesday, Sep 29. QTNT is lower by -$0.15 from the previous closing price of $5.32 on volume of 859,569 shares. Over the past year the S&P 500 is higher by 12.59% while QTNT is lower by -33.46%. QTNT lost -$1.40 per share in the over the last 12 months.

To see the top 5 stocks in the Diagnostics & Research industry click here.

More About Quotient Ltd

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the business of provision of tests with an initial focus on blood grouping and serological disease screening. The company develops and commercializes Mosaiq automation platform. Its product portfolio includes Red cell reagents, Antisera, Specialty products, Specialty kits etc. The firm operates in Edinburgh, Scotland, Eysins, Switzerland and Newton, Pennsylvania. It derives the majority of its revenue from the United States.

Click Here to get the full Stock Score Report on Quotient Ltd (QTNT) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Sector Update: Biotech Stocks Help Drag Health Care Sector Lower

Sector Update: Health Care

How Will the Market React to Gamida Cell Ltd (GMDA) Stock Getting a Bullish Rating

Is OrganiGram Holdings Inc (OGI) Stock About to Get Hot Monday?

Related Companies